A multiorganism pipeline for antiseizure drug discovery: Identification of chlorothymol as a novel γ‐aminobutyric acidergic anticonvulsant.

MLA

Jones, Alistair, et al. “A Multiorganism Pipeline for Antiseizure Drug Discovery: Identification of Chlorothymol as a Novel Γ‐aminobutyric Acidergic Anticonvulsant.” Epilepsia (Series 4), vol. 61, no. 10, Oct. 2020, pp. 2106–18. EBSCOhost, https://doi.org/10.1111/epi.16644.

APA

Jones, A., Barker, H. M., Ilie, A. S., Herd, M. B., Baxendale, S., Holdsworth, C. J., Ashton, J., Placzek, M., Jayasekera, B. A. P., Cowie, C. J. A., Lambert, J. J., Trevelyan, A. J., White, H. S., Marson, A. G., Cunliffe, V. T., Sills, G. J., & Morgan, A. (2020). A multiorganism pipeline for antiseizure drug discovery: Identification of chlorothymol as a novel γ‐aminobutyric acidergic anticonvulsant. Epilepsia (Series 4), 61(10), 2106–2118. https://doi.org/10.1111/epi.16644

Chicago

Jones, Alistair, Haliski, Melissa Barker, Andrei S. Ilie, Murray B. Herd, Sarah Baxendale, Celia J. Holdsworth, John‐Paul Ashton, et al. 2020. “A Multiorganism Pipeline for Antiseizure Drug Discovery: Identification of Chlorothymol as a Novel Γ‐aminobutyric Acidergic Anticonvulsant.” Epilepsia (Series 4) 61 (10): 2106–18. doi:10.1111/epi.16644.